Article Details
Retrieved on: 2025-06-25 09:25:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech SE (Nasdaq: BNTX) reported Q1 2025 financial results with revenues of €182.8 million, primarily driven by COVID-19 vaccine collaboration ...
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here